![Melinda Chavez](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Melinda Chavez
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Turn Therapeutics(TM), Inc
![]() Turn Therapeutics(TM), Inc Medical SpecialtiesHealth Technology Turn Therapeutics(TM), Inc is a pharmaceutical and medical device organization that aims to reduce the human and economic costs of infection and skin disease. Turn Therapeutics(TM is based in Calabasas, CA. The private company's core mission is to innovate and educate in order to render disease obsolete. The company has multiple, mass market-ready, proprietary assets incorporating advanced delivery and healing technologies, including their FDA cleared product, Hexagen® wound dressing, which is non-irritating, non-cytotoxic, and non-sensitizing, as well as suitable for extended-wear. The company was founded by Bradley Burnam, who has been the CEO since incorporation.
2
| Private Company | Medical Specialties | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Melinda Chavez via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
RELYPSA INC | Pharmaceuticals: Major | Director/Board Member | |
DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director of Finance/CFO | |
UCLA Anderson School of Management | College/University | Masters Business Admin | |
SYNLOGIC, INC. | Biotechnology | Chief Operating Officer | |
CYTEIR THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
AOBiome Therapeutics, Inc.
![]() AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
ATHIRA PHARMA, INC. | Biotechnology | Director of Finance/CFO | |
Baropace, Inc.
![]() Baropace, Inc. Electronic Equipment/InstrumentsElectronic Technology Baropace, Inc. is a privately held medical device company located in Ashland, OR. Baropace is focused on the development of pressurepace™, a real-time physiologic control software and hardware to regulate cardiac pacemakers to treat resistant hypertension and heart failure with preserved ejection fraction (hfpef). The company has proprietary biotechnologies including a pacemaker control algorithm (pressurepace™) and new sensor technologies working through patient mobile and wearable platforms. Baropace expects to launch a first-in-human clinical trial (relievehtn-i) in the fourth quarter of 2022. Pressurepace™ is limited by federal law to investigational use only and is not approved for sale in any geography. The company was founded in 2019 by Eli Gang and Michael Burnam, who has been the CEO since 2018. | Electronic Equipment/Instruments | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 16 |
Sectoraal
Health Technology | 12 |
Finance | 2 |
Commercial Services | 2 |
Consumer Services | 2 |
Electronic Technology | 2 |
Operationeel
Director/Board Member | 6 |
Corporate Officer/Principal | 5 |
Chief Executive Officer | 3 |
Director of Finance/CFO | 3 |
President | 2 |
Sterkste connecties
Insiders | |
---|---|
Andrew Gengos | 15 |
Bradley Burnam | 2 |
- Beurs
- Insiders
- Melinda Chavez
- Bedrijfsconnecties